REFERENCES
- Alssara I. A., Bosela A. A., Ahmed S. M., Mahrous G. M. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 2004; 20: 1–6
- Amato M., Isenschemid M., Huppi P. Percutaneous caffeine application in the treatment of neonatal apnoea. Eur. J. Pediatr. 1991; 150: 592–594
- Baker R. W., Lonsdale H. S. Controlled release: mechanisms and rates. Controlled Release of Biologically Active Agents, A. C. Tanquary, R. E. Lacey. Plenum Press, New York 1974; 15–71
- Dias M., Farinha A., Faustino E., Hadgraft J., Pais J., Toscano C. Topical delivery of caffeine from some commercial formulations. Int. J. Pharm. 1999; 182: 41–47
- Essig D., Costill D. L., Van Handel P. J. Effects of caffeine ingestion on muscle glycogen and lipid during leg ergometer cycling. Int. J. Sports Med. 1980; 1: 86–90
- Fadda A. M., Baroli B. M., Maccioni A. M., Sinico C., Valenti D., Alhaique F. Phospholipid-detergent systems: effects of polysorbates on the release of liposomal caffeine. Il Farmaco 1998; 53: 650–654
- Israelachvili J. N. Intermolecular and Surface Forces, , et al. Academic Press, Sydney 1985
- Lawrence M. J., Chauhan S., Lawrence S. M., Barlow D. J. The formation, characterization and stability of nonionic surfactant vesicles. STP Pharma. Sci. 1996; 6: 49–60
- Lu Y. P., Lou Y. R., Peng Q. Y., Xie J. G., Conney A. H. Stimulatory effect of topical application of caffeine on UVB-induced apoptosis in the epidermis of p53 and Bax knockout mice. Cancer Res. 2004; 64: 5020–5027
- Lu Y. P., Lou Y. R., Xie J. G., Peng Q. Y., Liao J., Yang C. S., Huang M. T. Topical applications of caffeine or (−)-epicatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. USA 2002; 99: 12455–12460
- Manosroi A., Wongtrakul P., Manosroi J., Saki H., Sugawara F., Yuasa M., Abe M. Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol. Colloid. Surfaces B: Biointerf. 2003; 30: 129–138
- Memisoglu E., Öner F., Ayhan A., Basaran I., Hincal A. A. In vivo evaluation of rhGM-CSF wound-healing efficacy in topical vehicles. Pharm. Dev. Tech. 1997; 2: 171–180
- Palozza P., Muzzalupo R., Trombino S., Valdannini A., Picci N. Solubilization and stabilization of β -carotene in niosomes: delivery to cultured cells. Chem. Phys. Lipids 2006; 139: 32–42
- Pardakhty A., Varshosaz J., Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int. J. Pharm. 2007; 328: 130–141
- Sawynok J., Yaksh T. L. Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol. Rev. 1993; 45: 43–85
- Schreiber S., Mahmoud A., Vuia A., Rubbelke M. K., Schmidt E., Schaller M., Kandarova H., et al. Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol. In Vitro 2005; 19: 813–822
- Shiraki K., Andoh T., Imakita M., Kurokawa M., Kuraishi Y., Niimura M., Kageyama S. Caffeine inhibits paresthesia induced by herpes simplex virus through action on primary sensory neurons in rats. Neurosci. Res. 1998; 31: 235–240
- Tabbakhian M., Tavakoli N., Jaafari M. R., Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes: 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int. J. Pharm. 2006; 323: 1–10
- Touitou E., Levy-Schaffer F., Dayan N., Alhaique F., Riccieri F. M. Modulation of caffeine skin delivery by carrier design: liposomes versus permeation enhancers. Int. J. Pharm. 1994; 103: 131–136
- Varshosaz J., Tavakoli N., Kheirolahi F. Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS Pharm. Sci. Tech. 2006; 7(1), article 24
- Waranuch N., Ramachandran C., Weiner N. D. Controlled topical delivery of cyclosporin-A from nonionic liposomal formulation: mechanistic aspects. J. Liposome Res. 1998; 8: 225–238
- Yamamura J., Koyasu M., Sato H., Kurokawa M., Yoshida Y., Amahabu Y., Shiraki K. Topical treatment of cutaneous herpes simplex virus-1 infection in mice with a specially formulated caffeine gel (Cafon). J. Dermatol. Sci. 1996; 12: 50–55
- Yoshioka T., Strenberg B., Florence A. T. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int. J. Pharm. 1994; 105: 1–6